{"cdcTestId":"2022-0074","testcaseName":"Dose # 1 PCV15 at age 6 weeks-4 days","vaccineGroup":"PCV","evaluationTestType":"Age: At Absolute Minimum","forecastTestType":"Recommended based on age","assessmentDate":"2022-10-19T00:00:00","patient":{"dob":"2022-09-11T00:00:00","gender":"F"},"evaluation":{"seriesStatus":"Not complete","administeredDoses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"VAXNEUVANCE","cvx":"215","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}]},"forecast":{"forecastNum":"2","earliestDate":"2022-11-20T00:00:00","recommendedDate":"2023-01-11T00:00:00","pastDueDate":"2023-03-10T00:00:00"},"doses":[{"dateAdministered":"2022-10-19T00:00:00","vaccineName":"VAXNEUVANCE","cvx":"215","mvx":"MSD","evaluationStatus":"Valid","evaluationReason":null}],"dateAdded":"2013-01-01T00:00:00","dateUpdated":"2022-09-15T09:25:34.047","generalDescription":"This test case describes when dose #1 of the PCV15 vaccine is administered at 6 weeks - 4 days that the dose is considered to be valid.","changedInVersion":"4.27","reasonForChange":""}